Antimicrobial Drugs (the stuff Dr. Figueroa didn - PowerPoint PPT Presentation

1 / 20
About This Presentation
Title:

Antimicrobial Drugs (the stuff Dr. Figueroa didn

Description:

Antimicrobial Drugs (the stuff Dr. Figueroa didn t tell you about in MIP) Jeffery A. Hobden, Ph.D. Wonder Drugs Decreased morbidity and mortality in US after WWII ... – PowerPoint PPT presentation

Number of Views:265
Avg rating:3.0/5.0
Slides: 21
Provided by: jhobde
Category:

less

Transcript and Presenter's Notes

Title: Antimicrobial Drugs (the stuff Dr. Figueroa didn


1
Antimicrobial Drugs(the stuff Dr. Figueroa
didnt tell you about in MIP)
  • Jeffery A. Hobden, Ph.D.

2
Wonder Drugs
  • Decreased morbidity and mortality in US after
    WWII from infectious diseases
  • Made practical some areas of medicine
  • Cancer chemotherapy
  • Gut surgery
  • Increased productivity in agriculture

3
Antibiotics - Exploited
  • In 2007, two antibiotics were in the top 20 drugs
    prescribed in the US
  • Amoxicillin 34,801,000
  • Azithromycin 23,782,000
  • In 2000, 24 million pounds of antibiotics were
    used in agriculture (chickens, pigs, cattle, etc)
    vs. 3 million pounds used to treat sick humans
  • Unrestricted access

4
Top 20 Prescribed Drugs
5
Tainted Seafood
  • Chinese seafood tested between 10/06 and 05/07
    were repeatedly positive for
  • Nitrofuran
  • Malachite green
  • Fluoroquinolones
  • Shipments banned from entering US
  • Buy only local seafood!

Alabama officials hold a press conference
Drugs in your seafood are bad, MKay?
6
The Consequences
That which does not kill us makes us stronger.
- Friedrich Nietzsche
7
Cant we just get more?
  • Screening natural or synthetic compounds for
    antibacterial activity
  • Preclinical studies (animals)
  • Safety (what is safe for animals may not be true
    for humans)
  • Efficacy (pharmacological parameters are
    different in animals)

8
Wait theres more
  • Clinical studies (humans)
  • Phase 1 short term studies in small number of
    healthy humans or patients with target disease,
    to determine metabolism and basic pharmacologic
    and toxicological properties of antibiotic
  • Phase 2 first controlled clinical studies to
    assess the effectiveness of the antibiotic and to
    determine short-term side effects and risks.
  • Phase 3 expanded controlled and uncontrolled
    clinical studies to gather data regarding benefit
    risk relationship.
  • Phase 4 marketing!

9
Is it any wonder?
  • Antibiotics are big business for pharm
  • Freebies
  • Advertising
  • Sponsorships
  • Not as profitable as drugs for erectile
    dysfunction, cholesterol control, anxiety
    attacks, etc.

10
After MIP, what else is there to know about
antibiotics?
  • Whats the origin of that antibiotic?
  • Whats special about its chemistry?
  • What happens to it after its in my body?
  • Will it kill or maim me if I take it?

11
Classification of Antibioticsby Mechanism of
Action
  • Inhibition of cell wall synthesis
  • Beta-lactam drugs
  • Penicillins
  • Cephalosporins
  • Carbapenems
  • The others
  • Cycloserine
  • Vancomycin
  • bacitracin

12
Classification of Antibioticsby Mechanism of
Action
  • Disruption of cell membranes
  • Polymyxin
  • Polyenes (anti-fungal agents)

13
Classification of Antibioticsby Mechanism of
Action
  • Inhibition of protein synthesis
  • Reversible inhibition (bacteristatic)
  • Chloramphenicol
  • The tetracyclines
  • The macrolides (erythromycin)
  • Clindamycin
  • Streptogramins
  • Linezolid
  • Irreversible the bactericidal aminoglycosides

14
Susceptibility and Resistance
  • In vitro values are guides, not rules
  • In vivo, bug is resistant if cidal concentrations
    are toxic to the host
  • Achievable serum concentrations are what
    determine susceptibility or resistance to drug
  • Low pH, high protein concentrations, anoxia
  • Pharmacological parameters of drugs (serum versus
    other bodily fluids)

15
Bacterial Mechanisms of Resistance
  • Prevent antibiotic from reaching its target
  • Destroy or inactivate antibiotic before it
    reaches target
  • Alter target

16
Choosing the right antibiotic is it really
needed?
  • Nature of the illness is it a bacterial
    infection or something else?
  • Presumptive diagnosis (based on history and
    clinical symptoms) says yes!
  • Empiric therapy broad spectrum drug
  • Specific therapy narrow spectrum

17
Choosing the right antibiotic pharmacokinetic
considerations.
  • Location of infection
  • Some antibiotics may or may not reach therapeutic
    concentrations in certain bodily fluids (ex. CSF
    and urine)
  • Degree to which antibiotic binds serum proteins
  • Excessive binding will affect passive diffusion
    of antibiotic from serum to tissue

18
Choosing the right antibiotic host factors.
  • Status of host immune system (cidal vs. static)
  • Local environment of infected site (pus, foreign
    bodies, etc)
  • Age (organ function in newborns and elderly)
  • Inherited metabolic disorder
  • Pregnancy (fetal or neonatal development)

19
Choosing the right antibiotic host factors.
  • drug allergies
  • Rashes
  • Anaphylaxis
  • Co-morbid conditions are aggravated by some
    antibiotics
  • Seizures
  • Blood disorders

SJS Syndrome
20
First up.
  • The sulfonamides
  • The quinolones
  • The beta-lactams
  • Penicillins
  • Cephalosporins
  • Carbapenems

Looking a-head.
Write a Comment
User Comments (0)
About PowerShow.com